Scarica l'app Stockscreener
0.222
7.04%
-0.0168
Dopo l'orario di chiusura:
.21
-0.012
-5.41%
China Pharma Holdings Inc. Borsa (CPHI) Ultime notizie
China Pharma announces 1-for-10 reverse stock split - Investing.com Australia
China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split - MarketScreener
HSI Down 352 pts; HSTI Down 113 pts; BABA Down over 5%; HK & CHINA GAS, WH GROUP, SIMCERE PHARMA, CQRC BANK, CZBANK Hit New Highs; Market Turnover Rises - AASTOCKS.com
China NT Pharma Reports Significant Losses for 2024 - TipRanks
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates - Yahoo Finance
Big pharma faces headwinds in China as vaccine sales decline - Yahoo
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025 - Yahoo Finance
China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update - Quantisnow
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - Yahoo Finance
Hedge funds, pharma CEOs on list of attendees for China business summit - Yahoo Finance
Prefilled Syringes Market Hits New High | Major Giants Weigao Group, YPSOMED AG , Boditech Med Inc - Newstrail
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance
Is Zoetis Inc. (ZTS) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance
SEC Form 10-K filed by Corbus Pharmaceuticals Holdings Inc. - Quantisnow
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate - Yahoo Finance
Is PDD Holdings Inc. (PDD) the Cheap Chinese Stock to Buy Now? - Insider Monkey
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday - Yahoo Finance
Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ... - Yahoo Finance
Alliance Pharma And 2 Other UK Penny Stocks With Promising Fundamentals - Yahoo Finance
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ... - Yahoo Finance
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Can Euro Tech's $2.2M Water Treatment Deals Signal Growth in China's Environmental Tech Market? - StockTitan
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why - Defense World
Chinese researchers find bat virus enters human cells via same pathway as COVID - Reuters
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - The Manila Times
Allspring Global Investments Holdings LLC Decreases Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - The AM Reporter
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire
InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance
U.S. investors, Big Pharma race to find new medicines in China - MSN
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate - Yahoo Finance
Hong Kong Stock Exchange Companies List - Morningstar.com.au
China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex
Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex
Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance
Wall Street Today: US stocks open flat amid China’s response to Trump tariffs; Nvidia up 3.19% - Mint
China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance
3 Leading Dividend Stocks Including Dawnrays Pharmaceutical Holdings - Simply Wall St
China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks
5.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):